investigating the incidence and outcomes of cns relapse in patients with all
Published 1 year ago • 297 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
2:34
improving outcomes for patients who relapse after allosct & evaluating cd19 cars against emd in all
-
3:36
the long-term outcomes of consolidative allosct for bpdcn
-
2:28
investigating the impact of pacritinib on survival in patients with mf and severe thrombocytopenia
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
1:44
the outcomes of patients with al amyloidosis and end-stage renal disease
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
14:24
the theory of everything
-
2:39
batang na-diagnose na may acute lymphocytic leukemia, cancer-free na ngayon
-
3:56
the future of cancer treatment is here: introducing proton therapy
-
0:50
insights into the phase ii window-2 trial
-
1:29
preventing the risk of infection in patients with b-cell malignancies in the era of novel agents
-
0:41
isct in bringing together the scientific community
-
1:38
an update on the optic study: adjusting the dose of ponatinib for cp-cml
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
1:10
the importance of incorporating patient-reported outcomes in clinical practice
-
2:20
ultra high-risk myeloma
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
5:07
daratumumab in the management of al amyloidosis